| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 302.3 | 229.0 |
| Profit before tax | 14.2 | 9.4 |
| Net income | 9.6 | 6.1 |
| EPS (diluted, $ a share) | $0.26 | $0.17 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +58.5% |
|---|---|
| Revenue, year on year | +32.0% |
| Operating margin | 5.5% |
10-Q filed with the SEC, NASDAQ: PNTG. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Pennant Group, Inc.: key numbers
- Share price
- $37.03Close, Nov 16
- Market cap
- $1.3B
- Shares outstanding
- 35.13MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Pennant Group, Inc.
All →Pennant Group Financial Results
The Pennant Group reported third quarter 2026 financial results, featuring a 32% year-over-year revenue increase to $302.3 million. The company achieved GAAP diluted EPS of $0.26 and adjusted diluted EPS of $0.35, driven by strong growth in its Home Health and Hospice Services segment.
- Term
- Q3 2026